Next-Generation Sequencing (NGS) Market to Grow at 20.5% CAGR to 2022

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market.

Click  Here for Complete Report on  Next-Generation   Sequencing   Market   spread across 215 Pages, Profiling 13 Companies and Supported with 96 Tables and 35 Figures at http://www.rnrmarketresearch.com/next-generation-sequencing-ngs-market-by-platforms-hiseq-miseq-hiseq-x-ten-x-five-nextseq500-ion-proton-pgm-ions5-pacbio-sequel-services-targeted-sequencing-de-novo-application-diagnostic-drug-ts-to-2021-market-report.html .

On the basis of product and service, the Next-Generation Sequencing Market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2017, the consumables segment is expected to account for the largest share of the market.

Introduction

1 Objectives of the Study

2 Market Definition

3 Market Scope

4 Currency

5 Limitations

6 Stakeholders

On the basis of technology, the global Next-Generation Sequencing Market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. In 2017, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina’s systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten.

Click Here for Sample Papers of Next-Generation Sequencing Market with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=507635 .

Geographically, the Next-Generation Sequencing Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the market in 2017, followed by Europe. The market in North America is primarily driven by the technological advancements, availability of commercial solutions for NGS data analysis, and the strong presence of key players in this region.

Appendix

1 Discussion Guide

2 Knowledge Store: Marketsandmarkets’ Subscription Portal

3 Introducing RT: Real-Time Market Intelligence

4 Available Customizations

5 Related Reports

6 Author Details

The global Next-Generation Sequencing Market is highly competitive, with a large number of global and local players. In 2016, the global NGS market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.),and together held the majority share of the NGS platforms market. New product launches, product enhancements, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market.

Click Now for More Details on “Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) – Global Forecasts to 2022” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=507635 .

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

Request to Call Back:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.